Overview
Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP)
Status:
Completed
Completed
Trial end date:
2005-02-01
2005-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the effect of 6 weeks of treatment with Rosuvastatin with 6 weeks of treatment with Atorvastatin in Hispanic subjects with hypercholesterolemiaPhase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
AstraZenecaTreatments:
Atorvastatin
Atorvastatin Calcium
Rosuvastatin Calcium
Criteria
Inclusion Criteria:- Fasting low density lipoprotein & triglyceride levels as defined by the protocol.
- Self described Hispanic race
- Subjects with coronary heart disease or at high risk of coronary heart disease.
Exclusion Criteria:
- The use of lipid lowering drugs or dietary supplements after Visit 1.
- Active arterial disease eg Unstable angina, or recent arterial surgery
- Blood lipid levels above the limits defined in the protocol.
- Uncontrolled hypertension, hypothyroidism, alcohol or drug abuse.